ANDA 75810, held by Barr. Fluoxetine Hydrochloride.
As of Nov 16, 2026, ANDA 75810 (Fluoxetine Hydrochloride), held by Barr, was first approved by FDA on Feb 1, 2002, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 1, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluoxetine HydrochlorideEQ 10MG BASE · tablet;oral | Fluoxetine Hydrochloride | Discontinued |
| Nov 17, 2014 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 26, 2003 | Supplement 2Labeling | Approved | None posted |
| Sep 26, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Feb 1, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters